Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

VillageMD is set to receive a total of $1bn in equity and convertible debt financing from Walgreens Boots Alliance over the next three years, giving the corporate a 30% stake.

Chalmers Ventures head of startups Stina Linge will leave on September 2 to head up Lipidor's animal health products unit Emollivet.

Lundbeckfonden Ventures took a board seat at Leiden spinout VarmX as part of a round that will fund development of a treatment for spontaneous bleeding.

The cancer therapy developer boosted its overall funding to more than $200m in a round that included series A backer Takeda Ventures.

Lundbeckfonden Ventures took a board seat at VarmX as part of a $36.2m round that will fund development of a treatment for spontaneous bleeding.

Baylor College spinout AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.

Stem-cell cancer treatment developer Vor Biopharma has collected more capital from investors including existing backers Johnson & Johnson and PureTech Health.

Gilead-backed AlloVir has filed to raise up to $100m in an offering that will support the clinical development of a treatment for viral diseases.

UCHealth and Children’s Hospital Colorado are among the limited partners for the University of Colorado-affiliated healthcare technology fund.